Phase 3 trial results demonstrate the superiority of long-acting injectable cabotegravir + rilpivirine over daily oral ...
A new injectable, temporary pacemaker could help correct a heart arrhythmia in an emergency. This nanoparticle gel can regulate the heart’s electrical signals for up to five days before dissolving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results